Literature DB >> 17286985

Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

S Boukhris1, L Magy, M Khalil, P Sindou, J-M Vallat.   

Abstract

Numerous clinical forms of CIDP have been described, but pain is generally considered a rare or secondary sign. We describe here the clinical, electrophysiological and neuropathological characteristics of five patients with CIDP and pain as the main presenting symptom, and their course with treatment. Between January 2003 and December 2004, we selected five patients with prominent or isolated pain among 27 patients diagnosed with CIDP. All patients were subjected to clinical and electrophysiological examinations, and had a complete laboratory work up to exclude other causes of neuropathy. In view of the atypical clinical presentation, all five patients underwent nerve biopsy. There were two men and three women. The mean age at onset of neuropathy was 70+/-7.39 years. All patients initially presented with pain in the lower limbs associated with modest motor impairment (1 case), distal paresthesia (4 cases), cramps (1 case) and fatigue (2 cases). CSF was normal in three cases. On electrophysiological examination, three patients had nerve conduction abnormalities with subtle or clear signs of demyelination: three (case 1, 2 and 4) fulfilled the criteria of Rotta et al. and two (case 2 and 4) the criteria of both Nicolas et al and the INCAT group. Patients were all given symptomatic treatment and four patients received an immunomodulatory treatment, which was constantly effective. Pain may be a major and disabling symptom in patients with CIDP, so this diagnosis has to be considered in patients referred for a painful polyneuropathy. Moreover, immunomodulatory treatment has to be considered in such patients as symptomatic therapy may be ineffective.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286985     DOI: 10.1016/j.jns.2006.12.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

2.  Exploring neuropathic symptoms in a large cohort of Italian patients with different peripheral nervous system diseases.

Authors:  Marta Lucchetta; Costanza Pazzaglia; Luca Padua; Chiara Briani
Journal:  Neurol Sci       Date:  2011-03-02       Impact factor: 3.307

Review 3.  Cytokine and chemokine regulation of sensory neuron function.

Authors:  Richard J Miller; Hosung Jung; Sonia K Bhangoo; Fletcher A White
Journal:  Handb Exp Pharmacol       Date:  2009

Review 4.  Chemokines and the pathophysiology of neuropathic pain.

Authors:  Fletcher A White; Hosung Jung; Richard J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-14       Impact factor: 11.205

5.  Depression with Chronic Inflammatory Demyelinating Polyneuropathy.

Authors:  Arun Marwale; Manaswi Gautam; Gaurav Murambikar; Manik Bhise; Anand Soni
Journal:  Indian J Psychol Med       Date:  2018 Nov-Dec

Review 6.  Pain in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.

Authors:  Athena Michaelides; Robert D M Hadden; Ptolemaios G Sarrigiannis; Marios Hadjivassiliou; Panagiotis Zis
Journal:  Pain Ther       Date:  2019-06-14

7.  Mitochondrial damage and "plugging" of transport selectively in myelinated, small-diameter axons are major early events in peripheral neuroinflammation.

Authors:  Marija Sajic; Keila Kazue Ida; Ryan Canning; Norman A Gregson; Michael R Duchen; Kenneth J Smith
Journal:  J Neuroinflammation       Date:  2018-02-27       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.